| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NRI.2017.100 |
| P698 | PubMed publication ID | 28869253 |
| P50 | author | Giulia Fornasa | Q58924256 |
| P2093 | author name string | Maria Rescigno | |
| Ilaria Spadoni | |||
| P2860 | cites work | Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging | Q24600644 |
| Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine | Q24609125 | ||
| Pericytes are required for blood-brain barrier integrity during embryogenesis | Q24627396 | ||
| CNS immune privilege: hiding in plain sight | Q24642697 | ||
| Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis | Q24681191 | ||
| Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders | Q26777279 | ||
| Sleep and gastrointestinal disturbances in autism spectrum disorder in children | Q26783381 | ||
| Role of gut microbiota in the modulation of atherosclerosis-associated immune response | Q26801649 | ||
| Development and functions of the choroid plexus-cerebrospinal fluid system | Q26801821 | ||
| Retinoic acid induces blood-brain barrier development. | Q39205654 | ||
| Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. | Q39275409 | ||
| The predominant site of bacterial translocation across the intestinal mucosal barrier occurs at the advancing disease margin in Crohn's disease | Q39600588 | ||
| Recruitment of pericytes and astrocytes is closely related to the formation of tight junction in developing retinal vessels | Q39935875 | ||
| Gene expression profile of endothelial cells during perturbation of the gut vascular barrier. | Q40471016 | ||
| Effect of short-chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model | Q41118303 | ||
| Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations | Q41138099 | ||
| Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. | Q41675605 | ||
| Mesenteric lymph nodes at the center of immune anatomy | Q42108522 | ||
| Origin of the lamina propria dendritic cell network | Q42117974 | ||
| Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. | Q42138485 | ||
| The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota | Q42214432 | ||
| Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. | Q43081763 | ||
| Diabetes and hypercholesterolemia increase blood-brain barrier permeability and brain amyloid deposition: beneficial effects of the LpPLA2 inhibitor darapladib | Q44980018 | ||
| Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. | Q45943518 | ||
| Colonic inflammation in Parkinson's disease. | Q46015750 | ||
| Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. | Q46040098 | ||
| Early retinal and renal abnormalities in diabetes | Q46075141 | ||
| The somnogenic T lymphocyte suppressor prostaglandin D2 is selectively elevated in cerebrospinal fluid of advanced sleeping sickness patients. | Q46794773 | ||
| Development, maintenance and disruption of the blood-brain barrier | Q26829668 | ||
| Oral tolerance to food protein | Q27026259 | ||
| Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity | Q27329095 | ||
| Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice | Q28203769 | ||
| T cell exclusion, immune privilege, and the tumor microenvironment | Q28259872 | ||
| Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood | Q28292031 | ||
| Essential regulation of CNS angiogenesis by the orphan G protein-coupled receptor GPR124. | Q28507603 | ||
| GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier | Q28509184 | ||
| Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature | Q28509331 | ||
| Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis | Q28594356 | ||
| Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown | Q28817495 | ||
| Ecological and evolutionary forces shaping microbial diversity in the human intestine | Q29547586 | ||
| A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism | Q29614266 | ||
| Molecular analysis of commensal host-microbial relationships in the intestine | Q29614776 | ||
| Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid | Q29615586 | ||
| Pericytes regulate the blood-brain barrier | Q29615840 | ||
| Normal gut microbiota modulates brain development and behavior | Q29616855 | ||
| Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders | Q29617111 | ||
| Bifidobacteria can protect from enteropathogenic infection through production of acetate | Q29617592 | ||
| Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis | Q29619978 | ||
| Revisiting the Mechanisms of CNS Immune Privilege | Q30278584 | ||
| Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells | Q30476839 | ||
| Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner | Q33553749 | ||
| Conditional Müllercell ablation causes independent neuronal and vascular pathologies in a novel transgenic model | Q33581991 | ||
| Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. | Q33717326 | ||
| The treatment-naive microbiome in new-onset Crohn's disease | Q33762817 | ||
| Comparison of sensitivity of Th1, Th2, and Th17 cells to Fas-mediated apoptosis | Q33859990 | ||
| Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease? | Q33949335 | ||
| Anatomical basis of tolerance and immunity to intestinal antigens | Q33965210 | ||
| Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo | Q34049368 | ||
| Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail--chick transplantation chimeras | Q34057185 | ||
| The development of blood-retinal barrier during the interaction of astrocytes with vascular wall cells | Q34096257 | ||
| The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy. | Q34100527 | ||
| Multiple facets of intestinal permeability and epithelial handling of dietary antigens | Q34110996 | ||
| SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier | Q34206194 | ||
| Epithelial barrier: an interface for the cross-communication between gut flora and immune system | Q34240555 | ||
| Celiac disease and its link to type 1 diabetes mellitus. | Q34274386 | ||
| Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates | Q48151397 | ||
| Rejection of fetal neocortical neural transplants by H-2 incompatible mice | Q48201567 | ||
| Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione | Q48217613 | ||
| Gradual Suppression of Transcytosis Governs Functional Blood-Retinal Barrier Formation | Q48249430 | ||
| The role of Müller cells in the formation of the blood-retinal barrier | Q48257006 | ||
| Retinal pathology is associated with increased blood-retina barrier permeability in a diabetic and hypercholesterolaemic pig model: Beneficial effects of the LpPLA2 inhibitor Darapladib. | Q48260488 | ||
| The fate of allogeneic and xenogeneic neuronal tissue transplanted into the third ventricle of rodents | Q48278859 | ||
| CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis | Q48365016 | ||
| ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage | Q48461941 | ||
| Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice | Q48479409 | ||
| The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence | Q48797548 | ||
| Claudin-1, claudin-2 and claudin-11 are present in tight junctions of choroid plexus epithelium of the mouse | Q48828901 | ||
| Brain endothelium lack one of two pathways of P-selectin-mediated neutrophil adhesion. | Q48829755 | ||
| Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. | Q49014751 | ||
| Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease | Q49037483 | ||
| Inhibition of antigen-stimulated effector T cells by human cerebrospinal fluid | Q49068413 | ||
| Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease | Q49245290 | ||
| Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. | Q50302739 | ||
| Evaluation of Intestinal Function in Children With Autism and Gastrointestinal Symptoms | Q50306071 | ||
| Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor. | Q51019927 | ||
| Astrocytes induce blood–brain barrier properties in endothelial cells | Q57318253 | ||
| Increased intestinal permeability precedes clinical onset of type 1 diabetes | Q79211266 | ||
| Retinal and ciliary body pigment epithelium suppress activation of T lymphocytes via transforming growth factor beta | Q80332034 | ||
| Oral tolerance can be established via gap junction transfer of fed antigens from CX3CR1⁺ macrophages to CD103⁺ dendritic cells | Q87163156 | ||
| Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management | Q37304800 | ||
| Perivascular spaces and the two steps to neuroinflammation | Q37329042 | ||
| Immune privilege or privileged immunity? | Q37349741 | ||
| Incidence of gastrointestinal symptoms in children with autism: a population-based study | Q37353825 | ||
| Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling | Q37451950 | ||
| Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders | Q37456857 | ||
| The gut immune barrier and the blood-brain barrier: are they so different? | Q37616357 | ||
| Immune privilege of the CNS is not the consequence of limited antigen sampling | Q37653497 | ||
| Capture, crawl, cross: the T cell code to breach the blood-brain barriers | Q38038445 | ||
| Postbiotics: what else? | Q38070062 | ||
| Extraintestinal manifestations and complications in IBD. | Q38120146 | ||
| Barrier properties of cultured retinal pigment epithelium | Q38204565 | ||
| The choroid plexuses and their impact on developmental neurogenesis | Q38266875 | ||
| Intestinal mucosal tolerance and impact of gut microbiota to mucosal tolerance | Q38335183 | ||
| Claudin-1, -2 and -3 Are Selectively Expressed in the Epithelia of the Choroid Plexus of the Mouse from Early Development and into Adulthood While Claudin-5 is Restricted to Endothelial Cells | Q38582363 | ||
| Intestinal Dysbiosis, Gut Hyperpermeability and Bacterial Translocation: Missing Links Between Depression, Obesity and Type 2 Diabetes. | Q38964759 | ||
| Gut Microbiota, Bacterial Translocation, and Interactions with Diet: Pathophysiological Links between Major Depressive Disorder and Non-Communicable Medical Comorbidities. | Q39018851 | ||
| The movers and shapers in immune privilege of the CNS. | Q39090554 | ||
| Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder | Q39135788 | ||
| Gastrointestinal problems in children with autism, developmental delays or typical development | Q34382693 | ||
| Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system | Q34398632 | ||
| Pre-eclampsia and pregnancy-induced hypertension are associated with severe diabetic retinopathy in type 1 diabetes later in life | Q34407459 | ||
| Host microbiota constantly control maturation and function of microglia in the CNS. | Q34478756 | ||
| Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. | Q34518641 | ||
| Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor. | Q34582564 | ||
| The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system | Q34798439 | ||
| Immunological Markers for PML Prediction in MS Patients Treated with Natalizumab | Q34818048 | ||
| Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. | Q34853757 | ||
| Autistic disorder and gastrointestinal disease | Q34916579 | ||
| Microbiota controls the homeostasis of glial cells in the gut lamina propria | Q35013616 | ||
| Development of the choroid plexus and blood-CSF barrier | Q35140713 | ||
| Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. | Q35168188 | ||
| The gut microbiota and developmental programming of the testis in mice | Q35223991 | ||
| Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats | Q35313910 | ||
| The gut microbiota influences blood-brain barrier permeability in mice | Q35413892 | ||
| A review of the influence of aqueous humor on immunity | Q35620171 | ||
| Role of the gastrointestinal ecosystem in the development of type 1 diabetes. | Q35624584 | ||
| Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. | Q35750345 | ||
| A gut-vascular barrier controls the systemic dissemination of bacteria. | Q35840463 | ||
| ApoE deficiency compromises the blood brain barrier especially after injury. | Q35944147 | ||
| The Central Nervous System and the Gut Microbiome. | Q36182979 | ||
| Gut microbiota influences pathological angiogenesis in obesity-driven choroidal neovascularization | Q36196897 | ||
| Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease | Q36212145 | ||
| Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes | Q36323689 | ||
| Complexity and developmental changes in the expression pattern of claudins at the blood-CSF barrier. | Q36353414 | ||
| See no evil, hear no evil, do no evil: the lessons of immune privilege | Q36426813 | ||
| Plasmacytoid dendritic cells mediate oral tolerance | Q36534744 | ||
| Ocular autoimmunity: the price of privilege? | Q36593726 | ||
| Immune privilege in the gut: the establishment and maintenance of non-responsiveness to dietary antigens and commensal flora | Q36593729 | ||
| Fecal microbiota composition differs between children with β-cell autoimmunity and those without | Q36720600 | ||
| Commensal microbiota is fundamental for the development of inflammatory pain. | Q36883155 | ||
| Wnt/beta-catenin signaling controls development of the blood-brain barrier | Q36955697 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cooperation | Q380962 |
| P304 | page(s) | 761-773 | |
| P577 | publication date | 2017-09-04 | |
| P1433 | published in | Nature Reviews Immunology | Q43355 |
| P1476 | title | Organ-specific protection mediated by cooperation between vascular and epithelial barriers | |
| P478 | volume | 17 |
| Q92876148 | AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer |
| Q57476572 | CNS infection and immune privilege |
| Q89481420 | CX3CR1+ Macrophages and CD8+ T Cells Control Intestinal IgA Production |
| Q95642060 | Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway |
| Q55364545 | Emerging concepts in non-invasive monitoring of Crohn's disease. |
| Q96686040 | Emerging routes to the generation of functional β-cells for diabetes mellitus cell therapy |
| Q95840390 | Host-microbiota interactions in immune-mediated diseases |
| Q92153794 | How to Make Anticancer Drugs Cross the Blood-Brain Barrier to Treat Brain Metastases |
| Q90351914 | IGF-1, Inflammation and Retinal Degeneration: A Close Network |
| Q89878911 | Increased Colonic Permeability and Lifestyles as Contributing Factors to Obesity and Liver Steatosis |
| Q92032230 | Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives |
| Q90205918 | Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation |
| Q92865404 | Involvement of the central nervous system in acute lymphoblastic leukemia: opinions on molecular mechanisms and clinical implications based on recent data |
| Q64123933 | MMP (Matrix Metalloprotease)-9-Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause Vasculitis |
| Q92662501 | Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development |
| Q64904804 | Reprogramming Cells to Make Insulin. |
| Q55514994 | The meningeal and choroidal infiltration routes for leukocytes in stroke. |
| Q92735130 | The progress of gut microbiome research related to brain disorders |
| Q48022024 | Tissue-specific immunopathology during malaria infection |
| Q89457645 | Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology |
Search more.